Methods to assess drug permeability across the blood‐brain barrier
暂无分享,去创建一个
[1] Y. Sugiyama,et al. Brain efflux index as a novel method of analyzing efflux transport at the blood-brain barrier. , 1996, The Journal of pharmacology and experimental therapeutics.
[2] Christian R Noe,et al. In silico prediction models for blood-brain barrier permeation. , 2004, Current medicinal chemistry.
[3] H. Takanaga,et al. The l‐isomer‐selective transport of aspartic acid is mediated by ASCT2 at the blood–brain barrier , 2003, Journal of neurochemistry.
[4] H. Herzog,et al. Preferred Stereoselective Transport of the D-isomer of cis-4-[18F]fluoro-proline at the Blood–Brain Barrier , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[5] C. Ringbom,et al. Establishment and functional characterization of an in vitro model of the blood-brain barrier, comprising a co-culture of brain capillary endothelial cells and astrocytes. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[6] K. Nicolay,et al. Blood-brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis: a quantitative MRI study. , 2004, Brain : a journal of neurology.
[7] C R Ganellin,et al. Predicting the brain-penetrating capability of histaminergic compounds. , 1994, Drug design and discovery.
[8] Donald W. Miller,et al. Quantitative Assessment of HIV-1 Protease Inhibitor Interactions with Drug Efflux Transporters in the Blood–Brain Barrier , 2005, Pharmaceutical Research.
[9] Christophe Rousselle,et al. Development of an In Situ Mouse Brain Perfusion Model and its Application to mdr1a P-Glycoprotein-Deficient Mice , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[10] J Marshall,et al. Quantitative Measurement of Blood—Brain Barrier Permeability Using Rubidium-82 and Positron Emission Tomography , 1984, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[11] Z. Nagy,et al. Tight junctions of brain endothelium in vitro are enhanced by astroglia , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[12] M. Dehouck,et al. Drug transport to the brain: comparison between in vitro and in vivo models of the blood-brain barrier , 1995 .
[13] D. E. Clark,et al. Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration. , 1999, Journal of pharmaceutical sciences.
[14] Thomas S. Reese,et al. FINE STRUCTURAL LOCALIZATION OF A BLOOD-BRAIN BARRIER TO EXOGENOUS PEROXIDASE , 1967, The Journal of cell biology.
[15] Meihua Tu,et al. Development of a computational approach to predict blood-brain barrier permeability. , 2004, Drug metabolism and disposition: the biological fate of chemicals.
[16] T. Reese,et al. JUNCTIONS BETWEEN INTIMATELY APPOSED CELL MEMBRANES IN THE VERTEBRATE BRAIN , 1969, The Journal of cell biology.
[17] T. Nakanishi,et al. Evaluation of blood-brain barrier transporters by co-culture of brain capillary endothelial cells with astrocytes. , 2002, Drug metabolism and pharmacokinetics.
[18] M. Bradbury. The blood-brain barrier. Transport across the cerebral endothelium. , 1985, Circulation research.
[19] J. Ghersi-Egea,et al. Blood-brain interfaces: relevance to cerebral drug metabolism. , 1995, Toxicology letters.
[20] H. Groen,et al. New positron emission tomography tracer [11C]carvedilol reveals P‐glycoprotein modulation kinetics , 2005, British journal of pharmacology.
[21] H. Davson. Blood–brain barrier , 1977, Nature.
[22] D. Begley,et al. Flavonoid permeability across an in situ model of the blood-brain barrier. , 2004, Free radical biology & medicine.
[23] W. Pardridge,et al. CNS Drug Design Based on Principles of Blood‐Brain Barrier Transport , 1998, Journal of neurochemistry.
[24] W. Pardridge. Blood-brain barrier biology and methodology. , 1999, Journal of neurovirology.
[25] D. E. Clark. In silico prediction of blood-brain barrier permeation. , 2003, Drug discovery today.
[26] P Delorme,et al. An Easier, Reproducible, and Mass‐Production Method to Study the Blood–Brain Barrier In Vitro , 1990, Journal of neurochemistry.
[27] W. Elmquist,et al. Distribution of STI-571 to the Brain Is Limited by P-Glycoprotein-Mediated Efflux , 2003, Journal of Pharmacology and Experimental Therapeutics.
[28] M Gumbleton,et al. Progress and limitations in the use of in vitro cell cultures to serve as a permeability screen for the blood-brain barrier. , 2001, Journal of pharmaceutical sciences.
[29] W. Elmquist,et al. Separation methods that are capable of revealing blood-brain barrier permeability. , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[30] D Comar,et al. Tissue Distribution, Autoradiography, and Metabolism of 4‐(2′‐Methoxyphenyl)‐1‐[2′ ‐[N‐2″‐Pyridinyl)‐p‐[18F]Fluorobenzamido]ethyl]piperazine (p‐[18F]MPPF), a New Serotonin 5‐HT1A Antagonist for Positron Emission Tomography , 2000, Journal of neurochemistry.
[31] C. Rousselle,et al. Screening of Multidrug-Resistance Sensitive Drugs by In Situ Brain Perfusion in P-Glycoprotein-Deficient Mice , 2001, Pharmaceutical Research.
[32] W. Elmquist,et al. Drug transport studies using quantitative microdialysis. , 2003, Methods in molecular medicine.
[33] J. Taskinen,et al. Relationship between immobilised artificial membrane chromatographic retention and the brain penetration of structurally diverse drugs. , 1997, Journal of pharmaceutical and biomedical analysis.
[34] F. Joó,et al. Penetration of small molecular weight substances through cultured bovine brain capillary endothelial cell monolayers: the early effects of cyclic adenosine 3',5'‐monophosphate , 1995, Experimental physiology.
[35] I. Hidalgo,et al. Evaluation of the MDR-MDCK cell line as a permeability screen for the blood-brain barrier. , 2005, International journal of pharmaceutics.
[36] Harpreet S. Chadha,et al. Molecular Factors Influencing Drug Transfer across the Blood‐Brain Barrier , 1997, The Journal of pharmacy and pharmacology.
[37] K. Audus,et al. Characterization of an In Vitro Blood–Brain Barrier Model System for Studying Drug Transport and Metabolism , 1986, Pharmaceutical Research.
[38] W. Pardridge,et al. Log(BB), PS products and in silico models of drug brain penetration. , 2004, Drug discovery today.
[39] K. Audus,et al. Brain microvessel endothelial cell culture systems. , 1996, Pharmaceutical biotechnology.
[40] de Lange EC,et al. Microdialysis for pharmacokinetic analysis of drug transport to the brain. , 1999, Advanced drug delivery reviews.
[41] Peter L. Bonate,et al. Animal models for studying transport across the blood-brain barrier , 1995, Journal of Neuroscience Methods.
[42] L. Illum. Is nose‐to‐brain transport of drugs in man a reality? , 2004, The Journal of pharmacy and pharmacology.
[43] Frauke Zipp,et al. Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study. , 2004, Brain : a journal of neurology.
[44] I. Tamai,et al. Functional Clarification of MCT1-Mediated Transport of Monocarboxylic Acids at the Blood-Brain Barrier Using In Vitro Cultured Cells and In Vivo BUI Studies , 2004, Pharmaceutical Research.
[45] H. Kusuhara,et al. P-Glycoprotein mediates the efflux of quinidine across the blood-brain barrier. , 1997, The Journal of pharmacology and experimental therapeutics.
[46] H. Galla,et al. Primary cultures of brain microvessel endothelial cells: a valid and flexible model to study drug transport through the blood-brain barrier in vitro. , 2000, Brain research. Brain research protocols.
[47] A. Hersey,et al. Blood-brain barrier transport of synthetic adenosine A1 receptor agonists in vitro: structure transport relationships. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[48] I. Pastan,et al. A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[49] S. Nag,et al. Cerebral cortical changes in acute experimental hypertension: An ultrastructural study. , 1977, Laboratory investigation; a journal of technical methods and pathology.
[50] Donald W. Miller,et al. Pluronic P 85 Enhances the Delivery of Digoxin to the Brain : In Vitro and in Vivo Studies , 2001 .
[51] Q. Smith. Brain perfusion systems for studies of drug uptake and metabolism in the central nervous system. , 1996, Pharmaceutical biotechnology.
[52] W. Pardridge. Transport of small molecules through the blood-brain barrier: biology and methodology. , 1995, Advanced drug delivery reviews.
[53] Y. Sawada,et al. Comparison of blood-brain barrier permeability in mice and rats using in situ brain perfusion technique. , 2000, American journal of physiology. Heart and circulatory physiology.
[54] Hans-Joachim Galla,et al. An improved low-permeability in vitro-model of the blood–brain barrier: transport studies on retinoids, sucrose, haloperidol, caffeine and mannitol , 1999, Brain Research.
[55] Stefan Lundquist,et al. The use of in vitro cell culture models for mechanistic studies and as permeability screens for the blood-brain barrier in the pharmaceutical industry--background and current status in the drug discovery process. , 2002, Vascular pharmacology.
[56] Elizabeth C M de Lange,et al. Potential role of ABC transporters as a detoxification system at the blood-CSF barrier. , 2004, Advanced drug delivery reviews.
[57] I. Klebovich,et al. Whole‐body Autoradiography and Quantitative Organ‐level Distribution Study of Deramciclane in Rats , 1999, The Journal of pharmacy and pharmacology.
[58] M. Bradbury. The blood‐brain barrier , 1993, Experimental physiology.
[59] U. Norinder,et al. Computational approaches to the prediction of the blood-brain distribution. , 2002, Advanced drug delivery reviews.
[60] M. Brightman,et al. Morphology of blood-brain interfaces. , 1977, Experimental eye research.
[61] Thomas J. Raub. Signal transduction and glial cell modulation of cultured brain microvessel endothelial cell tight junctions. , 1996, The American journal of physiology.
[62] M. J. Coloma,et al. Transport Across the Primate Blood-Brain Barrier of a Genetically Engineered Chimeric Monoclonal Antibody to the Human Insulin Receptor , 2000, Pharmaceutical Research.
[63] S. Yamada,et al. Blood-Brain Barrier Transport of 125I-Labeled Basic Fibroblast Growth Factor , 2004, Pharmaceutical Research.
[64] Kelly H. Jordan,et al. P-glycoprotein influences the brain concentrations of cetirizine (Zyrtec), a second-generation non-sedating antihistamine. , 2003, Journal of pharmaceutical sciences.
[65] Donald W. Miller,et al. Pluronic P85 enhances the delivery of digoxin to the brain: in vitro and in vivo studies. , 2001, The Journal of pharmacology and experimental therapeutics.
[66] W. Pardridge,et al. Capillary Depletion Method for Quantification of Blood–Brain Barrier Transport of Circulating Peptides and Plasma Proteins , 1990, Journal of neurochemistry.
[67] U. Bickel,et al. Delivery of peptides and proteins through the blood-brain barrier. , 1993, Advanced drug delivery reviews.
[68] D. Breimer,et al. The transference of results between blood-brain barrier cell culture systems. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[69] D. Scherman,et al. Functional Expression of P‐Glycoprotein in an Immortalised Cell Line of Rat Brain Endothelial Cells, RBE4 , 1996, Journal of neurochemistry.
[70] W. Pardridge,et al. Comparison of in vitro and in vivo models of drug transcytosis through the blood-brain barrier. , 1990, The Journal of pharmacology and experimental therapeutics.
[71] D. Mankoff,et al. Imaging P‐glycoprotein Transport Activity at the Human Blood‐brain Barrier with Positron Emission Tomography , 2005, Clinical pharmacology and therapeutics.
[72] M. Chopp,et al. Quantitative Evaluation of BBB Permeability after Embolic Stroke in Rat Using MRI , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[73] Gerhard F. Ecker,et al. In silico prediction models for blood-brain barrier permeation. , 2004, Current medicinal chemistry.
[74] D. Breimer,et al. Astrocytes Increase the Functional Expression of P-Glycoprotein in an In Vitro Model of The Blood-Brain Barrier , 2000, Pharmaceutical Research.
[75] D. Piwnica-Worms,et al. Characterization of a novel 99mTc-carbonyl complex as a functional probe of MDR1 P-glycoprotein transport activity. , 2002, Molecular imaging.
[76] W. Pardridge,et al. Determination of in vivo steady-state unbound drug concentration in the brain interstitial fluid by microdialysis , 1992 .
[77] C. Nitsch,et al. The blood-brain barrier to horseradish peroxidase at the onset of bicuculline-induced seizures in hypothalamus, pallidum, hippocampus, and other selected regions of the rabbit , 2004, Acta Neuropathologica.
[78] D. Piwnica-Worms,et al. Characterization of phosphine complexes of technetium(III) as transport substrates of the multidrug resistance P-glycoprotein and functional markers of P-glycoprotein at the blood-brain barrier. , 1997, Biochemistry.
[79] B. Kiss,et al. PET studies on the brain uptake and regional distribution of [11C]vinpocetine in human subjects , 2002, Acta neurologica Scandinavica.
[80] Y. Sugiyama,et al. Efflux of taurocholic acid across the blood-brain barrier: interaction with cyclic peptides. , 1998, The Journal of pharmacology and experimental therapeutics.
[81] Gert Luurtsema,et al. Evaluation of (R)-[11C]verapamil as PET tracer of P-glycoprotein function in the blood-brain barrier: kinetics and metabolism in the rat. , 2005, Nuclear medicine and biology.
[82] A. Hamberger,et al. Intracerebral Dialysis and the Blood‐Brain Barrier , 1995, Journal of neurochemistry.
[83] P. Meier,et al. Localization of the Organic Anion Transporting Polypeptide 2 (Oatp2) in Capillary Endothelium and Choroid Plexus Epithelium of Rat Brain , 1999, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[84] I. Tamai,et al. Transport mechanism for aluminum citrate at the blood-brain barrier: kinetic evidence implies involvement of system Xc- in immortalized rat brain endothelial cells. , 2005, Toxicology letters.
[85] W H Oldendorf,et al. Measurement of brain uptake of radiolabeled substances using a tritiated water internal standard. , 1970, Brain research.
[86] R Griffiths,et al. Development of a new physicochemical model for brain penetration and its application to the design of centrally acting H2 receptor histamine antagonists. , 1988, Journal of medicinal chemistry.
[87] A. Samii,et al. Blood-brain barrier transport of neuropeptides: analysis with a metabolically stable dermorphin analogue. , 1994, The American journal of physiology.
[88] S. Rapoport,et al. Examination of Blood — Brain Barrier Permeability in Dementia of the Alzheimer Type with [68Ga]EDTA and Positron Emission Tomography , 1987, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[89] C. Pidgeon,et al. IAM chromatography: an in vitro screen for predicting drug membrane permeability. , 1995, Journal of medicinal chemistry.
[90] D. Piwnica-Worms,et al. Characterization of a Novel 99mTc-Carbonyl Complex as a Functional Probe of MDR1 P-Glycoprotein Transport Activity , 2002 .
[91] M. Feher,et al. A simple model for the prediction of blood-brain partitioning. , 2000, International journal of pharmaceutics.
[92] R. Hurst,et al. Properties of an immortalised vascular endothelial/glioma cell co‐culture model of the blood‐brain barrier , 1996, Journal of cellular physiology.
[93] D. Piwnica-Worms,et al. Effects of MDR1 and MDR3 P-glycoproteins, MRP1, and BCRP/MXR/ABCP on the transport of (99m)Tc-tetrofosmin. , 2000, Biochemical pharmacology.
[94] S. Rapoport,et al. An in situ brain perfusion technique to study cerebrovascular transport in the rat. , 1984, The American journal of physiology.
[95] M. Melamed,et al. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[96] K. Read,et al. Brain penetration of synthetic adenosine A1 receptor agonists in situ: role of the rENT1 nucleoside transporter and binding to blood constituents. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[97] Q. Smith,et al. In situ brain perfusion technique. , 2003, Methods in molecular medicine.
[98] J. Brillault,et al. Prediction of Drug Transport Through the Blood-Brain Barrier in Vivo: A Comparison Between Two in Vitro Cell Models , 2002, Pharmaceutical Research.
[99] Tanja Eisenblätter,et al. A new multidrug resistance protein at the blood-brain barrier. , 2002, Biochemical and biophysical research communications.
[100] S. Nag. Cold-Injury of the Cerebral Cortex: Immunolocalization of Cellular Proteins and Blood-Brain Barrier Permeability Studies , 1996, Journal of neuropathology and experimental neurology.
[101] R. Lawrence. William Pardridge discusses the lack of BBB research , 2002 .
[102] W. Pardridge. Crossing the blood-brain barrier: are we getting it right? , 2001, Drug discovery today.
[103] Q. Smith,et al. A review of blood-brain barrier transport techniques. , 2003, Methods in molecular medicine.
[104] Michał J. Markuszewski,et al. Brain/blood distribution described by a combination of partition coefficient and molecular mass , 1996 .
[105] T. Tsuruo,et al. Efflux of a suppressive neurotransmitter, GABA, across the blood–brain barrier , 2001, Journal of neurochemistry.
[106] K. Audus,et al. Angiotensin Peptide Regulation of Bovine Brain Microvessel Endothelial Cell Monolayer Permeability , 1991, Journal of Cardiovascular Pharmacology.
[107] M. Dehouck,et al. Drug transfer across the blood-brain barrier: Correlation between “in vitro” and “in vivo” models , 1992, Neurochemistry International.
[108] K. Audus,et al. Changes in brain microvessel endothelial cell monolayer permeability induced by adrenergic drugs. , 1994, European journal of pharmacology.
[109] William M Pardridge. Holy grails and in vitro blood-brain barrier models. , 2004, Drug discovery today.
[110] I. Fritz,et al. Preliminary Characterization of Glial-Secreted Factors Responsible for the Induction of High Electrical Resistances Across Endothelial Monolayers in a Blood-Brain Barrier Model , 1998, Neurochemical Research.
[111] M. Takano,et al. Transport of prostaglandin E1 across the blood‐brain barrier in rats , 2005, The Journal of pharmacy and pharmacology.
[112] K. Audus,et al. Transport mechanisms for the antidepressant citalopram in brain microvessel endothelium , 1999, Brain Research.
[113] Andreas Reichel,et al. An overview of in vitro techniques for blood-brain barrier studies. , 2003, Methods in molecular medicine.
[114] Joseph W. Polli,et al. Role of P-Glycoprotein on the CNS Disposition of Amprenavir (141W94), an HIV Protease Inhibitor , 1999, Pharmaceutical Research.
[115] O. H. Chan,et al. Use of immobilized artificial membrane chromatography for drug transport applications. , 1998, Journal of pharmaceutical sciences.
[116] W. Banks,et al. Passage of erythropoietic agents across the blood-brain barrier: a comparison of human and murine erythropoietin and the analog darbepoetin alfa. , 2004, European journal of pharmacology.